?unique=be6aa15)
Linagliptin Methyldimer (>85%)
Impurity Linagliptin Dimer Impurity
Stability Light Sensitive
Applications Linagliptin Methyldimer inhibits dipeptidylpeptidase-IV (DPP-IV) and may be used in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);